Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：120
|
作者：
Gonzalez-Martin, A. [1 ,2 ,3 ,4 ,21 ]
Harter, P. [5 ]
Leary, A. [6 ]
Lorusso, D. [7 ,8 ]
Miller, R. E. [9 ,10 ]
Pothuri, B. [11 ]
Ray-Coquard, I. [12 ,13 ]
Tan, D. S. P. [14 ,15 ,16 ,17 ]
Bellet, E. [18 ]
Oaknin, A. [19 ]
机构：
[1] Univ Navarra, Canc Ctr Clin, Dept Med Oncol, Madrid, Spain
[2] Univ Navarra, Canc Ctr Clin, Program Solid Tumors Cima, Madrid, Spain
[3] Univ Navarra, Canc Ctr Clin, Dept Med Oncol, Pamplona, Spain
[4] Univ Navarra, Canc Ctr Clin, Program Solid Tumors Cima, Pamplona, Spain
[5] Ev Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany
[6] Univ Paris Saclay, Gustave Roussy Canc Ctr, Dept Med Oncol, INSERM U981, Paris, France
[7] Fdn Policlin Univ Agostino Gemelli IRCSS, Div Gynecol Oncol, Rome, Italy
[8] Univ Cattolica Sacro Cuore, Dept Woman Child & Publ Hlth, Rome, Italy
[9] Univ Coll Hosp, Dept Med Oncol, London, England
[10] St Bartholomews Hosp, Dept Med Oncol, London, England
[11] NYU, Perlmutter Canc Ctr, Dept Obstet & Gynecol, NYU Langone Hlth,Sch Med, New York, NY USA
[12] Ctr Leon Bernard, Dept Med Oncol, Lyon, France
[13] Univ Claude Bernard Lyon I, Lyon, France
[14] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[15] Natl Univ Singapore, NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore
[16] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore
[17] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[18] ACTO Alleanza Contro Tumore Ovar Onlus, Milan, Italy
[19] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Gynaecol Canc Programme, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[20] UCL, UCL Canc Inst, Dept Oncol, London, England
[21] ESMO Head Off, Via Ginevra 4, CH-6900 Lugano, Switzerland
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷 / 10期
关键词：
epithelial ovarian cancer; guideline; diagnosis; surgery; treatment; follow-up; PEGYLATED LIPOSOMAL DOXORUBICIN; PLATINUM-BASED CHEMOTHERAPY; PHASE-III TRIAL; CARBOPLATIN PLUS PACLITAXEL; CLEAR-CELL CARCINOMA; OPEN-LABEL; ADJUVANT CHEMOTHERAPY; FALLOPIAN-TUBE; NEOADJUVANT CHEMOTHERAPY; SECONDARY CYTOREDUCTION;
D O I：
10.1016/j.annonc.2023.07.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：833 / 848
页数：16
相关论文
共 50 条
  • [1] Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ledermann, J. A.
    Raja, F. A.
    Fotopoulou, C.
    Gonzalez-Martin, A.
    Colombo, N.
    Sessa, C.
    ANNALS OF ONCOLOGY, 2013, 24 : 24 - 32
  • [2] Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Colombo, N.
    Peiretti, M.
    Parma, G.
    Lapresa, M.
    Mancari, R.
    Carinelli, S.
    Sessa, C.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v23 - v30
  • [3] Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Obermannova, R.
    Alsina, M.
    Cervantes, A.
    Leong, T.
    Lordick, F.
    Nilsson, M.
    van Grieken, N. C. T.
    Vogel, A.
    Smyth, E. C.
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 992 - 1004
  • [4] Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Lordick, F.
    Carneiro, F.
    Cascinu, S.
    Fleitas, T.
    Haustermans, K.
    Piessen, G.
    Vogel, A.
    Smyth, E. C.
    ESMO Guidelines Committee
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 1005 - 1020
  • [5] Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Oaknin, A.
    Bosse, T. J.
    Creutzberg, C. L.
    Giornelli, G.
    Harter, P.
    Joly, F.
    Lorusso, D.
    Marth, C.
    Makker, V
    Mirza, M. R.
    Ledermann, J. A.
    Colombo, N.
    ANNALS OF ONCOLOGY, 2022, 33 (09) : 860 - 877
  • [6] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [7] Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Powles, T.
    Bellmunt, J.
    Comperat, E.
    De Santis, M.
    Huddart, R.
    Loriot, Y.
    Necchi, A.
    Valderrama, B. P.
    Ravaud, A.
    Shariat, S. F.
    Szabados, B.
    van der Heijden, M. S.
    Gillessen, S.
    ANNALS OF ONCOLOGY, 2022, 33 (03) : 244 - 258
  • [8] Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Vogel, A.
    Bridgewater, J.
    Edeline, J.
    Kelley, R. K.
    Klumpen, H. J.
    Malka, D.
    Primrose, J. N.
    Rimassa, L.
    Stenzinger, A.
    Valle, J. W.
    Ducreux, M.
    ANNALS OF ONCOLOGY, 2023, 34 (02) : 127 - 140
  • [9] Newly and relapsed epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Aebi, S.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 21 - 23
  • [10] Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up*
    Kraemer, A.
    Bochtler, T.
    Pauli, C.
    Baciarello, G.
    Delorme, S.
    Hemminki, K.
    Mileshkin, L.
    Moch, H.
    Oien, K.
    Olivier, T.
    Patrikidou, A.
    Wasan, H.
    Zarkavelis, G.
    Pentheroudakis, G.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 228 - 246
12345